Phyla is the first one stop shop for patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). With Phyla, patients can track their health using the Phyla app and gain access to comprehensive care; whether that be tests shipped directly to their door, personalized evidence based supplements or consultations with experts in digestive, mental or nutritional health.
By curating and delivering value through a comprehensive, personalized and digital experience patients can trust, Phyla is able to care for the silent sufferers of these life-long diseases.
Phyla hopes to support the use of novel technologies to improve the quality of life for all Canadians. As part of the QSCC, Phyla will receive real-world clinical feedback from patients and clinicians to enhance the maturity of our product offering. Allowing Phyla to further its progress towards promoting health through the development of next-generation AI, bioinformatics and digital health tools for all stages of the disease lifecycle, enabling a comprehensive understanding of the evolution of heterogeneous health data over time.